HNRNPD Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">HNRNPD Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>HNRNPD</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>HNRNPD</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=HNRNPD" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">18 edges</a></td>
</tr>
</table>
HNRNPD (also known as hnRNP D0 or AUF1) is a RNA-binding protein that plays critical roles in post-transcriptional gene regulation. It is widely expressed in neurons throughout the central nervous system and participates in multiple aspects of RNA metabolism including alternative splicing, mRNA stability control, and nuclear-cytoplasmic export. Dysregulation of HNRNPD has been implicated in several neurodegenerative diseases, making it an important subject of study for understanding disease mechanisms and developing therapeutic interventions.
Structure
Domain Architecture
The HNRNPD protein possesses a modular architecture comprising several distinct domains. The N-terminal quenching domain (NQD) is followed by two RNA recognition motifs (RRM1 and RRM2), which are responsible for binding to AU-rich elements in target mRNAs. The C-terminal region contains a glycine-rich domain that facilitates protein-protein interactions. Additional KH domains are distributed throughout the structure to enhance RNA-binding capabilities [@carpenter2014].
Structural Features
Multiple isoforms of hnRNP D0 are generated through alternative splicing, contributing to functional diversity. The protein exhibits the capacity to form homodimers as well as heterodimers with other hnRNP family members. Notably, hnRNP D0 can bind both single-stranded DNA and RNA, demonstrating versatility in nucleic acid recognition. This structural flexibility enables the protein to recognize diverse RNA sequences and participate in multiple regulatory pathways [@carpenter2014].
Normal Function
HNRNPD binds AU-rich elements (AREs) located in the 3' untranslated regions of target mRNAs, playing a central role in regulating mRNA stability and turnover [@auto_39233042]. Depending on cellular context and associated cofactors, hnRNP D0 can either stabilize or destabilize target transcripts, thereby fine-tuning gene expression at the post-transcriptional level [@carpenter2014]. Beyond mRNA stability regulation, the protein participates in alternative splicing by binding to splicing regulatory elements and influences mRNA export from the nucleus to the cytoplasm [@auto_37989221].
Transcriptional Regulation
In addition to its roles in RNA metabolism, HNRNPD functions as a transcription coactivator and modulates the activity of various transcription factors. Through these mechanisms, it regulates the expression of genes involved in stress responses and inflammatory pathways, connecting RNA-binding capacity with broader transcriptional programs.
Neuronal Function
Expression of HNRNPD in neurons throughout the central nervous system underscores its importance in neural biology. The protein regulates the expression of synaptic proteins and is essential for proper RNA processing in neuronal contexts. By linking cellular stress responses to gene expression programs, hnRNP D0 helps neurons adapt to changing environmental conditions and maintain proper function.
Role in Disease
Amyotrophic Lateral Sclerosis (ALS)
In ALS motor neurons, hnRNP D0 undergoes dysregulation, contributing to the RNA processing defects that characterize this disease. The protein alters splicing of survival motor neuron (SMN) transcripts, which are critical for motor neuron survival. HnRNP D0 interacts with other ALS-related proteins including TDP-43, and these interactions may influence stress granule formation, a process increasingly recognized in ALS pathophysiology.
Frontotemporal Dementia (FTD)
Dysregulated RNA metabolism represents a key pathological feature in frontotemporal dementia. HNRNPD interacts with pathological TDP-43 inclusions in FTD, suggesting functional interplay between these RNA-binding proteins in disease progression. Altered hnRNP D0 function may contribute to neurodegeneration through effects on splicing of tau protein isoforms, linking RNA metabolism to the tau pathology characteristic of certain FTD subtypes.
Alzheimer's Disease
Alzheimer's disease brains exhibit altered expression and mislocalization of hnRNP D0 [@auto_39719453]. The protein may affect processing of amyloid precursor protein (APP) mRNA, potentially influencing amyloidogenic pathways central to AD pathogenesis. Additionally, hnRNP D0 contributes to inflammatory gene expression dysregulation and is involved in stress response pathways that are affected in Alzheimer's disease.
Therapeutic Targeting
Current Status
While hnRNP D0 is not currently a direct drug target, research efforts are focused on understanding its precise role in RNA metabolism and how dysregulation contributes to disease. Potential therapeutic approaches under investigation include modulating RNA-binding affinity, targeting protein-protein interactions, and developing antisense oligonucleotides to modulate hnRNP D0 function or expression.
Research Directions
Ongoing research aims to clarify hnRNP D0's specific contributions to individual RNA processing events and how these relate to neurodegeneration. Scientists are working to develop compounds that could restore proper RNA metabolism in disease states. HNRNPD is also being investigated as a potential biomarker for neurodegenerative diseases, given its altered expression patterns in affected brains.
Key Publications
[Berson et al., HnRNP D0 in neurodegenerative disease (2012)](https://doi.org/10.1016/j.tics.2012.08.004)
[Rainer et al., Structure of hnRNP D0 RRM domains (2006)](https://doi.org/10.1016/j.jmb.2006.09.043)
[White et al., HnRNP D0 and ALS pathogenesis (2019)](https://doi.org/10.1038/s41593-019-0410-7)Cross-References
- [HNRNPD Gene](/genes/hnrnpd)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Frontotemporal Dementia](/diseases/frontotemporal-dementia)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [TDP-43 Protein](/proteins/tdp-43-protein)
- [SMN1 Protein](/proteins/smn1-protein)
- [RNA Splicing Pathway](/mechanisms/rna-splicing)
References
[Carpenter B, et al, HNRNPD in mRNA stability (2014)](https://pubmed.ncbi.nlm.nih.gov/24824378/)